Securonix, Inc. – Trademark Portfolio
Entity Type: 03
Securonix, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 2 are pending. Notable registered marks include X, SECURONIX, and UNIFIED DEFENSE SIEM. The owner is based in Addison, TX.
5080 Spectrum Drive, Suite 950W
Addison, TX 75001
Showing of trademarks Trademarks
Trademark Classifications
Securonix, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Securonix, Inc. have?
Securonix, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 pending.
What trademark classes does Securonix, Inc. file in?
Securonix, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Securonix, Inc.'s most well-known trademarks?
Securonix, Inc.'s registered trademark portfolio includes well-known marks such as X, SECURONIX, and UNIFIED DEFENSE SIEM. These are among 4 currently registered trademarks in the portfolio.
What is Securonix, Inc.'s trademark registration success rate?
Securonix, Inc. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 2 applications are pending review.